IDEAYA Biosciences, Inc. (IDYA)
33.86
-0.40
(-1.17%)
USD |
NASDAQ |
Oct 14, 16:00
33.51
-0.35
(-1.03%)
After-Hours: 20:00
IDEAYA Biosciences Total Long Term Debt (Quarterly) : 28.12M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 28.12M |
| March 31, 2026 | 28.25M |
| December 31, 2025 | 27.58M |
| September 30, 2025 | 26.92M |
| June 30, 2025 | 26.28M |
| March 31, 2025 | 25.66M |
| December 31, 2024 | 18.87M |
| September 30, 2024 | 18.80M |
| June 30, 2024 | 1.263M |
| March 31, 2024 | 1.256M |
| December 31, 2023 | 1.125M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.611M |
| March 31, 2023 | 1.116M |
| December 31, 2022 | 1.611M |
| September 30, 2022 | 2.097M |
| June 30, 2022 | 2.572M |
| Date | Value |
|---|---|
| March 31, 2022 | 3.031M |
| December 31, 2021 | 3.482M |
| September 30, 2021 | 3.924M |
| June 30, 2021 | 4.356M |
| March 31, 2021 | 4.773M |
| December 31, 2020 | 5.183M |
| September 30, 2020 | 5.584M |
| June 30, 2020 | 5.01M |
| March 31, 2020 | 5.321M |
| December 31, 2019 | 5.627M |
| September 30, 2019 | 5.926M |
| June 30, 2019 | 6.217M |
| March 31, 2019 | 6.498M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 393.58M |
| Xencor, Inc. | 166.19M |
| BioMarin Pharmaceutical, Inc. | 4.186B |
| MediciNova, Inc. | 0.00 |
| Viking Therapeutics, Inc. | 3.925M |